Literature DB >> 24853233

Down-regulated MAC30 expression inhibits proliferation and mobility of human gastric cancer cells.

Xiao-Yan Xu1, Li-Juan Zhang, Yan-Qiu Yu, Xiao-Tong Zhang, Wan-jing Huang, Xiao-Cui Nie, Guo-Qing Song.   

Abstract

BACKGROUND: Gastric cancer is one of the most common cancers in the world. MAC30/Transmembrane protein 97 (TMEM97) is aberrantly up-regulated in many human carcinoma cells. However, the function of MAC30 in gastric carcinoma cells is not studied.
MATERIAL AND METHODS: To investigate the function of MAC30 in gastric carcinoma, we used RNA silencing technology to knock down the expression of MAC30 in gastric cancer cells BGC-823 and AGS. Real-time quantitative PCR and Western blot were used to analyze the mRNA level and the related protein expression. The localization of MAC30 and lamellipodia was observed by immunofluorescence. The biological phenotypes of gastric cells were examined by cell proliferation assay, cell cycle analysis, apoptosis assay, cell migration and invasion assay.
RESULTS: We found that down-regulation of MAC30 expression efficiently inhibited the proliferation of gastric cancer cells. Furthermore, the mobility of gastric cancer cells was also inhibited by down-regulation of MAC30. Moreover, we found that MAC30 knockdown inhibited AKT phosphorylation and reduced the expression of cyclinB1 and WAVE2.
CONCLUSION: To our knowledge, this is the first report investigating the effect of MAC30 on growth, cell cycle, migration, and invasion in gastric carcinoma cells via suppressing AKT signaling pathway. MAC30 may be a potential therapeutic target for treatment of gastric carcinoma.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24853233     DOI: 10.1159/000358703

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  18 in total

Review 1.  Integrative Analysis of CD133 mRNA in Human Cancers Based on Data Mining.

Authors:  Gui-Min Wen; Fei-Fei Mou; Wei Hou; Dan Wang; Pu Xia
Journal:  Stem Cell Rev Rep       Date:  2019-02       Impact factor: 5.739

2.  Promyelocytic leukemia protein enhances apoptosis of gastric cancer cells through Yes-associated protein.

Authors:  Zhipeng Xu; Jiamin Chen; Liming Shao; Wangqian Ma; Dingting Xu
Journal:  Tumour Biol       Date:  2015-05-15

3.  MiR-429 regulates gastric cancer cell invasiveness through ZEB proteins.

Authors:  Wei Liu; Jie An; Kang Li; Huichi Hou
Journal:  Tumour Biol       Date:  2015-10-15

4.  miR-132 upregulation promotes gastric cancer cell growth through suppression of FoxO1 translation.

Authors:  Wei Li; Jixun Zhang; Teng Chen; Peihao Yin; Jiahua Yang; Yijun Cao
Journal:  Tumour Biol       Date:  2015-08-23

5.  Synthesis, Cytotoxicity Evaluation, and Computational Insights of Novel 1,4-Diazepane-Based Sigma Ligands.

Authors:  Daniele Zampieri; Sara Fortuna; Antonella Calabretti; Maurizio Romano; Renzo Menegazzi; Dirk Schepmann; Bernhard Wünsch; Maria Grazia Mamolo
Journal:  ACS Med Chem Lett       Date:  2019-12-16       Impact factor: 4.345

6.  Identification of the gene that codes for the σ2 receptor.

Authors:  Assaf Alon; Hayden R Schmidt; Michael D Wood; James J Sahn; Stephen F Martin; Andrew C Kruse
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-30       Impact factor: 11.205

7.  Fluorouracil induces autophagy-related gastric carcinoma cell death through Beclin-1 upregulation by miR-30 suppression.

Authors:  Chun Yang; Yong Pan
Journal:  Tumour Biol       Date:  2015-07-25

8.  miR-203 suppression in gastric carcinoma promotes Slug-mediated cancer metastasis.

Authors:  Yan Shi; Yong-Jia Tan; Dong-Zhu Zeng; Feng Qian; Pei-Wu Yu
Journal:  Tumour Biol       Date:  2015-07-21

9.  The Prognostic Effect of MAC30 Expression on Patients With Non-Small Cell Lung Cancer Receiving Adjuvant Chemotherapy.

Authors:  Hui Ding; Xianhua Gui; Xubo Lin; Ruhua Chen; Tieliang Ma; Yunlu Sheng; Hourong Cai; Yan Fen
Journal:  Technol Cancer Res Treat       Date:  2016-09-29

10.  MiR-153 regulates metastases of gastric cancer through Snail.

Authors:  Zhongli Wang; Chao Liu
Journal:  Tumour Biol       Date:  2015-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.